Balyasny Asset Management LLC Arcturus Therapeutics Holdings Inc. Transaction History

Balyasny Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$24.35 - $44.39 $1.02 Million - $1.86 Million	41,947 New	41,947 $1.02 Million
Q1 2023 May 15, 2023	SELL	$14.72 - $23.97 $13.2 Million - $21.5 Million	-896,582 Reduced 89.28%	107,653 $2.58 Million
Q4 2022 Feb 14, 2023	BUY	$14.14 - $23.06 $9.4 Million - $15.3 Million	664,852 Added 195.9%	1,004,235 $17 Million
Q3 2022 Nov 14, 2022	BUY	$13.05 - $22.13 $4.29 Million - $7.27 Million	328,574 Added 3039.82%	339,383 $5.03 Million
Q2 2022 Aug 15, 2022	BUY	$12.26 - $31.17 $132,518 - $336,916	10,809 New	10,809 $170,000
Q4 2020 Feb 16, 2021	SELL	$34.61 - $123.66 $921,595 - $3.29 Million	-26,628 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$37.49 - $63.19 $2.5 Million - $4.22 Million	-66,750 Reduced 71.48%	26,628 $1.14 Million
Q2 2020 Aug 14, 2020	BUY	$12.66 - $58.27 $1.18 Million - $5.44 Million	93,378 New	93,378 $4.36 Million

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $411M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.